Theophylline (Anhydrous) Extended-Release Tablets, 600 mg, 100 Tablets per bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited. Colvale-Bardez, Goa - 403513, India. Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430. NDC: 68462-356-01
Published June 4, 2025 · Recall initiated: May 15, 2025
Summary
FDA records drug Class II recall D-0452-2025, published June 4, 2025 and initiated May 15, 2025. Recalling firm: Glenmark Pharmaceuticals Inc., USA; Status: Ongoing; Reported quantity: 8,520 100-count bottles; Lot: Lots: 19234121, 19234148, Exp Sep-30-25; Lots 19242881, 19242899, Exp Jun-30-26. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
OOS results reported for the Dissolution (by UV) test.
What to do
Voluntary: Firm initiated · Letter
Get an email if THEOPHYLLINE has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- THEOPHYLLINE
- Manufacturer
- Glenmark Pharmaceuticals Inc., USA
- Distributor
- Nationwide in the USA
- UPC
- 0368462380017
- Lot
- Lots: 19234121, 19234148, Exp Sep-30-25; Lots 19242881, 19242899, Exp Jun-30-26
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDATheophylline extended-release tablets 400mg, 100-count bottle, Rx only, Manufactured by: GlenmarkAugust 20, 2025
- FDACarvedilol Tablets USP 25 mg, 500 -Count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd.,June 4, 2025
- FDAENDURANCE BOOST WITH HORNY GOAT WEED, 500mg, 20 capsules per carton, VEPEMVA Nutrition Supplement....rgy andJune 4, 2025
- FDACarvedilol Tablets USP 12.5 mg, 500-Count bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Ltd.,June 4, 2025
- FDAMauna Loa Dark Chocolate Covered Macadamias product is a snack product and packaged in 0.6oz and 4oz plasticJune 4, 2025
- FDATheophylline (Anhydrous) Extended-Release Tablets 400 mg 100 Tablets Rx Only NDC 68462-380-01 Manufactured by:June 2, 2021
Questions about this recall
Was Theophylline (Anhydrous) Extended-Release Tablets, 600 mg, 100 Tablets per bottle, Rx Only, Manufactured by: Glenmark Pharmaceuticals Limited. Colvale-Bardez, Goa - 403513, India. Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430. NDC: 68462-356-01 recalled?
Yes. FDA published recall D-0452-2025 on June 4, 2025. Reported hazard: OOS results reported for the Dissolution (by UV) test.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: THEOPHYLLINE. UPC: 0368462380017.